FALLON LYNNETTE C 4
4 · ClearPoint Neuro, Inc. · Filed Jun 5, 2025
Insider Transaction Report
Form 4
FALLON LYNNETTE C
Director
Transactions
- Sale
Common Stock
2025-06-03$12.53/sh−9,000$112,770→ 42,101 total - Sale
Common Stock
2025-06-03$12.88/sh−1,200$15,456→ 40,901 total
Footnotes (3)
- [F1]This sale of shares was made to cover the tax liability incident to the vesting of 21,903 shares on May 16, 2025 under a restricted stock unit granted to the director on May 16, 2024.
- [F2]Represents a weighted average sales price per share. The shares were sold at prices ranging from $11.84 to $12.81. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]Represents a weighted average sales price per share. The shares were sold at prices ranging from $12.84 to $12.92. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.